HIGHLIGHTS
- who: Marija Vukmiroviu0107 Papuga et al. from the Department of Pathophysiology and Laboratory Medicine, Faculty of Medicine, University of have published the research work: Serum Uromodulin, a Potential Biomarker of Tubulointerstitial Damage, Correlates Well with Measured GFR and ERPF in Patients with Obstructive Nephropathy, in the Journal: Medicina 2022, 58, 1729. of /2022/
- what: This study aimed to investigate the potential clinical significance of uromodulin (sUmod) as a marker of early kidney disfunction in patient with obstructive nephropathy (ON). Accurate measurements were used to evaluate glomerular and tubular function (by radioisotope clearance method), as well . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.